u/arne_amankwah

The discount was 98.4% but gas ate half of it. Still worth it but the math matters.

escrow for group buys is standard, use it

the people who came off and restarted without shame

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Copay was step therapy for the copay then another 2% of the total.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Not to be pedantic but discontinuation and tapering are being used interchangeably and they are not interchangeable in real life.

Yes, exactly this, and it is the bit that took me 39 weeks to accept.

research use only, handling and analysis, not protocols

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Mechanistically the bit that matters is retatrutide. It explains most of the early profile and a decent chunk of the outcome.

protein targets in g/kg

the regain is treatment of chronic condition ending, not failure

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

no group-buy recruitment, discussing how they fail is fine

New Zealand is different on the two sides

AU or NZ?

Strongly agree. If it is not working at 12.5mg after 96 weeks, going up is not automatically the answer.

Not convinced. The evidence does not support that reading.

Went up because the scale stalled, not because I needed to. Do not be me. The stall broke on its own at the higher dose.